The efficacy and safety of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis based on randomized controlled trials

The efficacy and safety of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis based on randomized controlled trials

BackgroundCabazitaxel (CAB) has been approved for the treatment of patients with progressed metastatic castration-resistant prostate cancer (mCRPC) after receiving docetaxel. To assess the efficacy and safety of CAB in mCRPC patients through systematic review and network meta-analysis.MethodsRandomi...

Full description

Saved in:
Bibliographic Details
Main Authors: Cong Shao, Quan Wan, Jia Guo, Zhuo Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
prostate cancer
castration resistance
cabazitaxel
meta-analysis
systematic review
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1586650/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1586650/full

Similar Items